Investment Highlights

As a uniquely positioned company in the growth segment of specialty pharmaceuticals, Medios AG is an outstanding competence partner for pharmaceutical companies, manufacturing companies and pharmacies. We are a first mover with clearly defined competitive advantages in the area of personalized medicine and realize ongoing profitable growth with low capital commitment as well as a clear growth strategy for further sales and earnings growth. Medios AG has a highly competent management with many years of industry and capital market experience.

Medios AG – Company Presentation (PDF 3 MB)

Key Facts

Strengthening of our leading position in Berlin and increase of our market share in Germany through our growing partner network and the acquisition of new clients.

Significant increase of our production capacity for personalized medication through investments in the construction of a new production facility.

Establishment of new, indication-specific “communities” through an extension of our product line and the targeting of new indication areas.

Optimization of business processes, leveraging of synergies and cost reduction by centralizing all activities of Medios Group in one location in Berlin.

Digitalization of pharmaceutical wholesale through the development of specialized software and infrastructure solutions.

More Information

Ad-Hoc News

Current announcements to our investors
View …


Information on the Medios AG shares
View …

Financial Reports

Financial Reports of Medios AG
View …


Information from external sources
View …

General Assembly

Dates and Documents
View …

Corporate Governance

Announcements and Voting Rights
View …

Our contact person.

Claudia Nickolaus
Head of Investor-/ Public Relations

Phone: +49 30 232 5668 00

Stay informed.

Register for our Investor Relations Info Mailing and receive automatic updates about all our mailings, current news and new financial reports that have been published. Registration is free and can be revoked by you at any time.